Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and OrganiGram Holdings (OGI)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novan (NOVN – Research Report) and OrganiGram Holdings (OGI – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
OrganiGram Holdings (OGI)
Haywood analyst Neal Gilmer maintained a Buy rating on OrganiGram Holdings yesterday and set a price target of C$3.25. The company’s shares closed last Tuesday at $1.96.
According to TipRanks.com, Gilmer is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for OrganiGram Holdings with a $2.63 average price target, representing a 46.1% upside. In a report released yesterday, Alliance Global Partners also maintained a Buy rating on the stock with a C$4.00 price target.
